Short-term statin therapy for prevention of contrast-induced AKI
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://www.nature.com/articles/nrneph.2013.249.pdf
Reference10 articles.
1. McCullough, P. A. et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am. J. Cardiol. 98, 5K–13K (2006).
2. Chang, C. F. & Lin, C. C. Current concepts of contrast-induced nephropathy: a brief review. J. Chin. Med. Assoc. http://dx.doi.org/10.1016/j.jcma.2013.08.011 .
3. Han, Y. et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.09.017 .
4. Leoncini, M. et al. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome. Results from protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS study). J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.04.105 .
5. Ho, J. E. et al. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the treating to new targets [TNT] study). Am. J. Cardiol. 109, 1761–1766 (2012).
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease;Progress in Cardiovascular Diseases;2022-07
2. Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-02-25
3. MicroRNA-30c attenuates contrast-induced acute kidney injury by suppressing NLRP3 inflammasome;International Immunopharmacology;2020-10
4. Non-Invasive Imaging for Evaluating Cardiovascular Involvement in Patients with Primary and Lupus Nephritis;The Open Rheumatology Journal;2019-12-31
5. Management of patients with type 2 diabetes mellitus and acute coronary syndrome: Better be safe than sorry!;Journal of Diabetes and its Complications;2019-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3